
CONGENITAL HEPATIC FIBROSIS AS AN EARLY SIGN
OF PRESENTATION OF ADPKD Sila L.1, Velmishi V.2,*, Saraci B.3, Dervishi E.2, Sila S.4, Shtiza D.5, Cullufi P.2 *Corresponding Author: PhD Virtut Velmishi, Work address: Pediatric department; Dibra Street
Nr 372, Tirana - Albania, e-mail: tutimodh@yahoo.com page: 91
|
DISCUSSION
Autosomal dominant polycystic kidney disease (ADKPD)
is the most frequent inherited renal cystic diseases
that is identified by the growth of renal cysts and a variety
of extra renal presentations. The report on the family shows
good evidence of multiple renal cysts, transmitted by the
family in a clear autosomal dominant pattern. In addition,
one of the members of the third generation presents Congenital
hepatic fibrosis .Despite being generally related to
ARPKD, a few cases also associate CHF to ADKPD [1-9].
The significance of their occurrence is uncertain; these
conditions have different modes of inheritance.
A similar case is reported by Tazeeler [9] in a 19 yearold
woman, whose family’s involvement with ADKPD
was known. She firstly presented with portal hypertension
and was eventually shown to have renal cysts and a family
history of ADKPD. Manifestations of portal hypertension
such as splenomegaly and variceal bleeding in early
infancy or during childhood led to a diagnosis of CHF.
Interestingly, some of these patients may be asymptomatic
for a significant period of time, resulting to an unexpected
CHF in adulthood [20].
Typical kidney and liver manifestation of ADKPD
developed in the fourth and fifth decade of life in patients.
Although, there are cases describing the presence of renal
symptoms in ADKPD even in infancy and early childhood
[5]. Similarly, as in our case, portal hypertension with CHF
might be the first presenting signs of ADKPD [10-13].
While to the contrary in ARPKD, renal disease frequently
precedes the symptoms related to CHF and complication
of portal hypertension [14-17]. ADKPD may be present
in childhood due to variability attributable to mutation
at more than one locus. The first locus PK1 is present on
chromosome 16 responsible for 85% of the cases. The
penetrance of the autosomal dominant gene of ADKPD
is almost 100%, so we needed to investigate the previous
generation in the family.
It is important to highlight that patients with ADKPD
may grow large kidney cysts similar to those found in
ARKPD, thus a family history is extremely important for
a proper diagnosis of ADKPD with CHF [18, 19]. In addition
to the renal cystic abnormalities in ADKPD, several
extra renal changes may be noted such as cysts in the liver, ovary, and seminal vesicles, abdominal hernias, cerebral
or aortic aneurysms [21, 22, and 23]. It is recommended to
monitor via ultrasound for ADKPD in these patients and
their family members. This case report highlights the value
of an accurate family history of polycystic kidney disease
in a child with these manifestations. Finding a normal
sized kidney at infancy is not unusual, since the expecting
incidence of kidney alteration is in the next decade of life.
Presentation with hepatosplenomegaly can mislead
to a late diagnosis. It is suggested that CHF should not
be considered as a distinctive condition, as it can still be
encountered in patients with ADKPD [24]. Due to such
variability, we should emphasize the significance of a detailed
family history of polycystic kidney disease in order
to determine the type (dominant or recessive disease), as
well as understanding other interrelated conditions.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|